Jefferson Life Sciences is an investment firm focused on advancing transformative innovations in medicine. As part of Jefferson River Capital, it supports companies across their lifecycle—from early development through commercialization—by combining intelligent financing with deep operational and scientific expertise to turn bold ideas into meaningful therapeutic solutions for patients. The firm collaborates with portfolio teams through strategic guidance, access to a wide network, and long-term partnerships to redefine standards of care and improve patient outcomes globally. Based in New York, the firm emphasizes partnering with world-class teams to accelerate breakthrough technologies in human health.
No recent news for this company.